
Steve Freedland MD
Surgical Oncology
Warschaw, Robertson, and Law Families Chair in Prostate Cancer, Professor of Urology
Join to view full profile
8635 W 3rd StLos Angeles, CA 90048
Phone+1 310-423-4700
Fax+1 310-423-4711
Dr. Freedland is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 1997 - 2003
University of California, Davis, School of MedicineClass of 1997
Certifications & Licensure
CA State Medical License 1999 - 2027
NC State Medical License 2005 - 2015
MD State Medical License 2003 - 2006
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Publications & Presentations
PubMed
- The effect of dutasteride on storage symptoms in men with lower urinary tract symptoms: a REDUCE trial analysis.Alexander Hernandez-Tirado, Renning Zheng, Eman Dadashian, Farnoosh Nik-Ahd, Daniel Moreira
The Aging Male. 2026-12-31 - Real-World Treatment Patterns for Patients with High-Risk Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer.Stephen J Freedland, Amanda Ribbands, David Russell, Jake Butcher, Tom Brown
Advances in Therapy. 2026-09-01 - Validation of the Prostatype® P-score for predicting prostate cancer specific mortality in a multiethnic U.S. veterans cohort.Alexandra Mack, Trung Duong Tran, Emelie Berglund, Gerald L Andriole, Christopher Alley
Prostate Cancer and Prostatic Diseases. 2026-09-01
Press Mentions
WebMD: Drug Combo Boosts Prostate Cancer Survival by 40%November 4th, 2025
High-Risk Prostate Cancer Survival Improved 40% with Drug ComboOctober 22nd, 2025
A New Drug Cocktail Shows Results in Treating Prostate CancerOctober 22nd, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









